The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both ...
LEXINGTON, Ky.--(BUSINESS WIRE)--Demeetra, a gene editing technologies company, is proud to announce that its research in collaboration with Variation Biosciences, Inc. “VBI” has been selected for an ...
These findings highlight the potential of self-complementary AAVs to reduce dose requirements, minimize toxicity, and broaden ...
NORMAN, OKLA. – A breakthrough study of freshwater harmful algal communities led by Dave Hambright, a Regents’ Professor of Biology at the University of Oklahoma, has discovered that complementary ...
We used a mathematical model and experiments with laboratory populations of Escherichia coli to examine conditions for the evolution of plasmids conferring resistance to multiple antibiotics. In our ...
AskBio and Belief BioMed will work together to advance potential gene therapies in diseases with high unmet medical need, using a liver-targeted approach Bayer AG and Asklepios BioPharmaceutical, Inc.
High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin’s Lymphoma: Results From the Randomized European CUP Trial Patients and Methods: Our series ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback